As the chart clearly shows a breakout with the significant volume on a monthly time frame it's clear that we can see the great opportunity in the long side and since the market and sector both are in a bullish phase we can see the target will be achieved in no time.
Dr Lal Pathlabs one of the largest players of healthcare industry in India has a beaten down stock price currently. It is approximately 53.29% down from it's lifetime high. There is not a single reason for such stock price. The company is posting good results and is consistently showing profits. But the stock is highly undervalued. It is a good time to buy it as...
Buy DrLALPATHLAB Target 🎯 4400 because it's recently given major breakout.
If close above this channel on 1 day time frame it can retest and make new highs
AB=CD Harmonic Rounding bottom breakout today 2300ish is turning out to be a solid support 4hr TF Swing position #Learning n sharing my view not an advise #DRLAL LONG